Kidney transplantation remains one of the most common organ transplanted today but the surgical technique has changed very little from the original pelvic operation. The deceased donor renal transplant poses a particular challenge to the surgeon due to lack of detailed pre operative vascular assessment. The hemopatch is a promising new sealing synthetic hemostatIc agent with a novel dual mechanism of action that is more convenient to apply rather then using other hemostatic agents, which require warming and/or mixing.

Inclusion Criteria:

• Patients at least 18 years of age and capable of giving informed consent
• Patients scheduled for deceased donor renal transplant surgery

Exclusion Criteria:

• Patient undergoing live related transplant surgery.
• Patient having uncorrectable bleeding diathesis.
• Any patient in the no hemopatch group requiring additional haemostatic agents for achieving hemostasis like fibrillar or surgical.